Martin Shkreli is an American entrepreneur and pharmaceutical executive who gained notoriety in 2015 for increasing the price of an anti-parasitic drug by 5,000%. He was subsequently convicted of securities fraud and sentenced to seven years in prison. Despite his controversial actions, Shkreli has become a figure of public interest and has been featured in numerous news outlets.
Martin Shkreli: Biography
Martin Shkreli was born on March 17, 1983 in Brooklyn, New York. He graduated from Hunter College High School in 2001 and attended Baruch College, but dropped out in 2004. Shkreli began working on Wall Street in 2006 and eventually founded a number of companies, including Turing Pharmaceuticals and KaloBios Pharmaceuticals. In 2015, Shkreli became the subject of public criticism when he increased the price of the anti-parasitic drug Daraprim by 5,000%. He was subsequently indicted on charges of securities fraud in December of 2015.
Martin Shkreli: Net Worth and More
Shkreli’s net worth is estimated to be $27 million. In addition to his business ventures, he has also gained notoriety for his music production, as he purchased the only existing copy of the Wu-Tang Clan album “Once Upon a Time in Shaolin” for $2 million in 2015. He has also been featured in numerous news outlets, including the New York Times, CNN, and the Wall Street Journal.
Martin Shkreli has become a controversial figure for his business practices and his public persona. While his actions have been criticized by many, he has also become a figure of public interest and has been featured in numerous news outlets. Despite being convicted of securities fraud and sentenced to seven years in prison, his net worth is estimated to be around $27 million.
